Novavax Inc (NVAX)
17.42
-0.80
(-4.39%)
USD |
NASDAQ |
Jun 04, 10:26
Novavax Cash from Financing (TTM): 364.73M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 364.73M |
December 31, 2023 | 4.466M |
September 30, 2023 | 95.52M |
June 30, 2023 | -132.58M |
March 31, 2023 | -189.26M |
December 31, 2022 | 324.99M |
September 30, 2022 | 72.84M |
June 30, 2022 | 88.09M |
March 31, 2022 | 44.59M |
December 31, 2021 | 461.71M |
September 30, 2021 | 927.03M |
June 30, 2021 | 920.37M |
March 31, 2021 | 1.376B |
December 31, 2020 | 984.76M |
September 30, 2020 | 610.32M |
June 30, 2020 | 644.74M |
March 31, 2020 | 228.13M |
December 31, 2019 | 98.38M |
September 30, 2019 | 72.07M |
June 30, 2019 | 61.06M |
March 31, 2019 | 115.06M |
December 31, 2018 | 102.80M |
September 30, 2018 | 116.36M |
June 30, 2018 | 138.97M |
March 31, 2018 | 93.10M |
Date | Value |
---|---|
December 31, 2017 | 64.54M |
September 30, 2017 | 47.89M |
June 30, 2017 | 24.74M |
March 31, 2017 | 16.86M |
December 31, 2016 | 279.85M |
September 30, 2016 | 279.28M |
June 30, 2016 | 287.33M |
March 31, 2016 | 291.14M |
December 31, 2015 | 208.28M |
September 30, 2015 | 208.35M |
June 30, 2015 | 200.41M |
March 31, 2015 | 304.04M |
December 31, 2014 | 109.72M |
September 30, 2014 | 109.54M |
June 30, 2014 | 228.33M |
March 31, 2014 | 125.02M |
December 31, 2013 | 131.04M |
September 30, 2013 | 157.97M |
June 30, 2013 | 45.98M |
March 31, 2013 | 53.71M |
December 31, 2012 | 53.79M |
September 30, 2012 | 28.61M |
June 30, 2012 | 22.15M |
March 31, 2012 | 17.04M |
December 31, 2011 | 11.13M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-189.26M
Minimum
Mar 2023
1.376B
Maximum
Mar 2021
352.89M
Average
163.26M
Median
Cash from Financing (TTM) Benchmarks
Pfizer Inc | 23.91B |
Moderna Inc | -821.00M |
Vaxart Inc | 32.02M |
Sensus Healthcare Inc | -0.046M |
Macrogenics Inc | 50.49M |